Both in Pharmaceuticals
Aquestive Therapeutics vs Gyre Therapeutics
Over the past year AQST returned −40.2% and GYRE returned −39.7%; their daily moves had a correlation of 0.16.
AQST −40.2% GYRE −39.7%Growth of $1, one year, split-adjusted
| Metric | AQST | GYRE |
|---|---|---|
| Price | $3.88 | $4.44 |
| Market cap | $487.0M | $470.8M |
| Today | +2.92% | −6.13% |
| 1 month | −15.1% | −39.6% |
| 6 months | −7.2% | −42.9% |
| Year to date | −39.9% | −37.1% |
| 1 year | −43.1% | −42.7% |
| Revenue growth (YoY) | +38.1% | −2.1% |
| Gross margin | 70.9% | 92.4% |
| Net margin | −165.5% | −40.1% |
| P/E (TTM) | — | — |
| Price / sales | 9.0× | 3.9× |
| Net cash | $47.8M | $74.8M |
| Dividend yield | — | — |
| Volatility (60d) | 54.4% | 88.3% |
| Short % of float | 25.6% | 11.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).